Today, we’re thrilled to unveil CluePoints’ latest release of its award-winning Risk-Based Monitoring Software. For this release, we wanted to hone in on several customer feature requests to deliver a solution that further advances the ability to meet the guidance proposed by regulators regarding Risk-Based Monitoring.
Recently, CluePoints has been taking time out with some of our valued partners to discuss hot topics in Risk-Based Monitoring (RBM). Here, in the second of an eight-part Q&A series, we spoke with Adam Butler, Senior Vice President, Strategic Development & Corporate Marketing at Bracket Global, who shared these valuable insights with us.
Last week CluePoints launched its eight-part Q&A blog series which aims to explore the current talking points in Risk-Based Monitoring (RBM). We’ve been gathering insights from a number of CluePoints’ partners but are keen to open up the discussion to the wider industry.…
In the first of an eight-part Q&A series which aims to explore some of the current hot topics in Risk-Based Monitoring (RBM), CluePoints has been speaking with Craig Serra from Pfizer. Craig is currently Senior Director and Data Management Business Process Owner, with accountability for the data management process in study conduct and closeout.
Join CluePoints CEO Francois Torche and OmniComm Sr. Director Steve Young at this special thought leadership event where you will hear about the benefits derived from an integrated solution for electronic data capture (EDC) technology, targeted source data verification (SDV), and centralized analytics/key risk indicators (KRIs).